FDA
-
-
-
-
-
-
-
("OKYO" or the "Company") - OKYO Pharma Announces Positive Data and Results in an Animal Model using Topically Administered OK-201 to Treat Neuropathic Ocular Pain
-
322,207 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

